Raia Drogasil SA (BSP:RADL3)
R$ 13.36 -0.27 (-1.98%) Market Cap: 22.89 Bil Enterprise Value: 30.15 Bil PE Ratio: 21.34 PB Ratio: 3.53 GF Score: 82/100

Q1 2025 Raia Drogasil S/A Earnings Call (English, Portuguese) Transcript

May 7, 2025 / 01:00 PM GMT
Release Date Price: R$16.58 (-14.76%)

Key Points

Positve
  • Raia Drogasil SA (RADLY) opened 75 new pharmacies in the first quarter, indicating expansion efforts.
  • The company achieved a significant increase in digital sales, growing by 40% to reach 2.2 billion in sales.
  • Raia Drogasil SA (RADLY) gained market share, increasing from 16.2% to 16.6%, despite overall market growth being below expectations.
  • The company maintained a high Net Promoter Score (NPS) of 90, reflecting strong customer satisfaction.
  • Raia Drogasil SA (RADLY) is focusing on digital and omnichannel strategies, with digital channels accounting for 22% of sales, enhancing customer engagement and sales potential.
Negative
  • The company's first-quarter sales and gross margin fell short of expectations, impacting EBITA and net income.
  • Raia Drogasil SA (RADLY) experienced a decrease in gross margin by 60 basis points, partly due to increased losses from shoplifting and expired products.
  • The company faced challenges from a calendar effect, with one fewer business day impacting sales across industries.
  • There was a noted decrease in the performance of Health and Beauty Care (HBC) products compared to prescription medications, affecting overall sales mix.
  • Raia Drogasil SA (RADLY) had to implement cost-cutting measures, including personnel reductions, to address financial pressures and improve efficiency.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RADL3.SA - Raia Drogasil S/A
Q1 2025 Raia Drogasil S/A Earnings Call (English, Portuguese)
May 07, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Will be available on our investor relations website at RI.rdsAud dotcom dot where the replay of this conference will also be made available later.

All participants will be in a listen-only mode during the presentation. After the presentation, we will begin the question and answer session.

Before proceeding, I'd like to mention that forward-looking statements are being made under the safe harbor of the Securities Litigation Reform Act of 1,996. Forward-looking statements are based on the beliefs and assumptions of RD Sauda's management and on information currently available to the company.

Forward-looking statements are not guarantees of performance. They involve risks, uncertainties, and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot